Drug
Tpm
Tpm: highest development phase Phase 2, developed by Supernus Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| IR-TPM (Topamax) NCT03280342 | Phase 2 | Migraine |
| TPM XR NCT01284530 | Phase 1/2 | Epilepsy |
Latest
No recent events.
Follow Tpm on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.